An IPI based immune prognostic model for diffuse large B-cell lymphoma
Shidai Mu, Deyao Shi, Lisha Ai, Fengjuan Fan, Fei Peng, Chunyan Sun, Yu Hu
The paper constructs an IPI-based immune prognostic model for DLBCL using gene expression data, showing high-risk patients have shorter survival and higher potential response to ICB therapy.
bioRxiv · Mar 3, 2021 · PreprintGenomics